Macy’s: Q2 Net Sales Rise To $4.9 Billion As Comparable Sales Gain 2.7% And FY2026 Guidance Increases

Macy's reported Q2 2026 net sales of $4.9B, up 1.1% YoY, with comparable sales rising 2.7%. All major brands saw growth, with Bloomingdale's up 11.3%. Gross margin increased to 41.5%, and net income nearly doubled. The company raised its FY2026 guidance for sales, EBITDA margin, and EPS. Macy's ended the quarter with $1.3B in cash and $2B in available credit.

Original reporting
Published Sep 13, 2026, 3:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 9:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Macy’s: Q2 Net Sales Rise To $4.9 Billion As Comparable Sales Gain 2.7% And FY2026 Guidance Increases — source image
Decision brief

The 30-second read

$MBullishHigh
01

Why it matters

The earnings beat and guidance raise suggest improved profitability and may trigger short covering.

02

Market read

Earnings beat and guidance lift for a major retailer; likely to influence consumer‑discretionary sentiment.

03

What to watch

Higher cash balance may fund future share buybacks or strategic investments, but rising debt could be a risk.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Macy's reported Q2 2026 results with net sales of $4.9B, GAAP EPS $0.62, and raised FY2026 guidance.

Company-level read

Ticker impact

$MBullishHigh confidence
Context

Macy's Q2 2026 earnings beat and raised FY2026 sales guidance to $21.675‑$21.825B.

Expected impact

Potential upside of 3‑5% over the next week if guidance is fully priced in.

Evidence & confidence

Guidance lift and beat on earnings are fresh, material, and likely to attract buyer interest.

Market effects

Retail sector may see a modest lift as Macy's signals strength in department‑store model.

U.S. consumer discretionary stocks could benefit from the upbeat guidance.

Limited; primarily U.S. retail investors.

Counterpoint

If the guidance fails to meet analyst expectations, the stock could face a pull‑back.

Key entities

  • Macy's

    U.S. department store operator (ticker M).

Related articles

$MMed

This Questionable Berkshire Hathaway Holding Actually Makes Sense

Berkshire Hathaway's investment in Macy's, a brick-and-mortar retailer, may seem questionable but shows potential. Macy's sales have stabilized, with same-store sales growing 2.7% last quarter, and the company raised its full-year revenue and earnings guidance. Analysts expect revenue to decline slightly but predict efficiency gains will boost earnings. Berkshire's stake, now 7.4 million shares, could be a turnaround play rather than a real estate bet, with Macy's trading at a low P/E ratio of 8

$MMed

Macy's (M) Raises Guidance And Finishes Buyback, Is The Stock Still Below Fair Value?

Macy's (M) reported earnings, raised guidance, and completed a multiyear buyback. The stock is down 6.84% in 30 days and 10.36% in 90 days, but up 27.25% in 1 year and 2.3x in 3 years. Analysts estimate a fair value of $22.77, slightly above the current $21.64, suggesting a small discount. The company's growth in luxury and off-price segments supports future revenue growth, but e-commerce competition and margin pressures remain concerns.

$MHighAI 8/10

Macy’s Earnings Call Signals Turnaround Momentum

Macy's (M) reported Q2 earnings that surpassed expectations, with revenue up 1.1% to $4.9B and adjusted EPS at $0.63. Comparable sales rose 2.7% across Macy's, Bloomingdale's, and Bluemercury. Management highlighted margin expansion, cash flow improvements, and strategic initiatives, while raising full-year guidance. However, third-quarter outlook remains cautious with flat-to-slightly-negative comps and a small EPS loss.

$MHighAI 8/10

Macy’s Posts Strong Financial Results And Raises Guidance

Macy’s (M) reported Q2 earnings of $0.40 per share, beating estimates, with revenue of $4.87B. Comparable sales rose 2.7%, with Bloomingdale’s and Bluemercury seeing significant gains. The company raised full-year guidance to $21.68B-$21.83B in sales and $2.15-$2.35 in EPS. M stock rose 4% premarket.